SMid Cap Biotech Analyst Cheng holds a conference call with President & CEO Leonard on December 1 at 11 am hosted by JPMorgan. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NTLA:
- Intellia Therapeutics 6.55M share Spot Secondary priced at $45.80
- Here’s Why Intellia (NASDAQ:NTLA) Stock Is Trending Lower
- Intellia Therapeutics to participate in a conference call with JPMorgan
- Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
- Intellia Therapeutics $250M Spot Secondary; price range $45.80-$47.80